Estrogen’s effects in chronic autoimmune/inflammatory diseases and progression to cancer

References

• Straub RH, Bijlsma JW, Masi A, Cutolo M. Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases - the 10-year update. Semin. Arthritis Rheum. doi:10.1016/j.semarthrit.2013.04.008 (2013) ( Epub ahead of print).
   Google Scholar
• Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 13, 217–226 (1995).
   PubMed Web of Science ®Google Scholar
• Lockshin MD. Sex ratio and rheumatic disease. Autoimmun. Rev. 1, 162–167 (2002).
   PubMedGoogle Scholar
• Kvien TK, Uhlig T, Ødegård S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann. NY Acad. Sci. 1069, 212–222 (2006).
   PubMed Web of Science ®Google Scholar
• Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford) 47( Suppl. 3), iii2–iii5 (2008).
   PubMedGoogle Scholar
• Magalhaes R, Stiehl P, Morawietz L, Berek C, Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch. 441, 415–427 (2002).
   PubMed Web of Science ®Google Scholar
• Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707–717 (2000).
   PubMed Web of Science ®Google Scholar
• Straub RH, Buttgereit F, Cutolo M. Benefit of pregnancy in inflammatory arthritis. Ann. Rheum. Dis. 64, 801–809 (2005).
   PubMed Web of Science ®Google Scholar
• Cutolo M, Brizzolara R, Atzeni F, Capellino S, Straub RH, Puttini PC. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann. NY Acad. Sci. 1193, 36–42 (2010).
   PubMedGoogle Scholar
• Straub RH. The complex role of estrogens in inflammation. Endocr. Rev. 28, 521–574 (2007).
   PubMed Web of Science ®Google Scholar
• Hansar Ahmed S, Hissong BD, Verthelyi K, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and autoimmune diseases: possible role of estrogenic compounds Environ. Health Perspect. 107, 681–687 (1999).
   Google Scholar
• Cutolo M, Sulli A, Straub RH. Estrogen metabolism and autoimmunity. Autoimmun. Rev. 11, A460–A464 (2012).
   PubMed Web of Science ®Google Scholar
• Villaggio B, Soldano S, Cutolo M. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin. Exp. Rheumatol. 30, 934–938 (2012)..
   PubMedGoogle Scholar
• Cutolo M. The challenges of using vitamin D in cancer prevention and prognosis. Isr. Med. Assoc. J. 14, 637–639 (2012).
   PubMedGoogle Scholar
• Castagnetta LA, Carruba G, Granata OM et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 30, 2597–2605 (2003).
   PubMed Web of Science ®Google Scholar
• Villaggio B, Soldano S, Cutolo M. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin. Exp. Rheumatol. 30, 934–938 (2012).
   PubMedGoogle Scholar
• Amaral C, Varela C, Borges M et al. Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis. Apoptosis 18(11), 1426–1436 (2013).
   PubMedGoogle Scholar
• Weidler C, Härle P, Schedel J, Schmidt M, Schölmerich J, Straub RH. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J. Rheumatol. 3, 489–494 (2004).
   Google Scholar
• Li KM, Todorovic R, Devanesan P et al. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25, 289–297 (2004).
   PubMed Web of Science ®Google Scholar
• Dubey RK, Tyurina YY, Tyurin VA et al. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ. Res. 84, 229–239 (1999).
   PubMed Web of Science ®Google Scholar
• Schmidt M, Hartung R, Capellino S, Cutolo M, Pfeifer-Leeg A, Straub RH. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum. 60, 2913–2922 (2009).
   PubMedGoogle Scholar
• Folomeev M, Dougados M, Beaune J et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1(3), 191–195 (1992).
   PubMedGoogle Scholar
• Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 50, 1967–1975 (2004).
   PubMed Web of Science ®Google Scholar
• Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum. 22, 1195–1198 (1979).
   Google Scholar
• Rakoff-Nahoum S. Why cancer and inflammation? Yale J. Biol. Med. 79, 123–130 (2006).
   PubMedGoogle Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357(9255), 539–545 (2001).
   PubMed Web of Science ®Google Scholar
• Khan WA, Moinuddin, Habib S. Preferential recognition of catechol-estrogen modified DNA by circulating autoantibodies in cancer patients. Biochimie 95, 329–335 (2013).
   PubMedGoogle Scholar
• Khan WA, Habib S, Khan WA, Alam K, Moinuddin. Enhanced binding of circulating SLE autoantibodies to catecholestrogen-copper-modified DNA. Mol. Cell Biochem. 315, 143–150 (2008).
   PubMedGoogle Scholar
• Khan WA, Uddin M, Khan MW, Chabbra HS. Catecholoestrogens: possible role in systemic lupus erythematosus. Rheumatology (Oxford) 48, 1345–1351 (2009).
   PubMed Web of Science ®Google Scholar
• Khan WA, Moinuddin, Assiri AS. Immunochemical studies on catechol-estrogen modified plasmid: possible role in rheumatoid arthritis. J. Clin. Immunol. 31, 22–29 (2011).
   PubMedGoogle Scholar
• Ostensen M, Brucato A, Carp H et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 50, 657–664 (2011).
   PubMed Web of Science ®Google Scholar
• Doria A, Iaccarino L, Sarzi-Puttini P et al. Pregnancy and systemic lupus erythematosus. Ann. NY Acad. Sci. 1069, 247–256 (2006).
   PubMed Web of Science ®Google Scholar
• Carvalheiras G, Vita P, Marta S et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin. Rev. Allergy Immunol. 38, 302–306 (2010).
   PubMed Web of Science ®Google Scholar
• Doria A, Cutolo M, Ghirardello A et al. Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res. Ther. 1, R66 (2012).
   Google Scholar
• Taraborelli M, Ramoni V, Brucato A et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum. 64, 1970–1977 (2012).
   PubMed Web of Science ®Google Scholar
• Soldano S, Montagna P, Brizzolara R et al. Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Ann. NY Acad. Sci. 1193, 25–29 (2010).
   PubMedGoogle Scholar
• Soldano S, Montagna P, Villaggio B et al. Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts. Ann. Rheum. Dis. 68, 599–602 (2009).
   PubMedGoogle Scholar
• Aida-Yasuoka K, Peoples C, Yasuoka H et al. Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Ann. Rheum. Dis. 15(1), R10 (2009).
   Google Scholar
• Cutolo M, Montagna P, Brizzolara R et al. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients. J. Autoimmun. 32, 254–260 (2009).
   PubMedGoogle Scholar
• Dziedziejko V, Kurzawski M, Safranow K, Chlubek D, Pawlik Aet al.. The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide. Pharmacogenomics 12(1), 41–47 (2011)
   Google Scholar
• Montagna P, Brizzolara R, Soldano S, Pizzorni C, Sulli A, Cutolo M. Sex hormones and leflunomide treatment of human macrophage cultures: effects on apoptosis. Int. J. Clin. Exp. Med. 2, 221–232 (2009).
   PubMedGoogle Scholar
• Montagna P, Soldano S, Brizzolara R et al. Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. Ann. NY Acad. Sci. 1193, 30–35 (2010).
   PubMedGoogle Scholar
• Mufudza C, Sorofa W, Chiyaka ET. Assessing the effects of estrogen on the dynamics of breast cancer. Comput. Math. Methods Med. 2012, 473572 (2012).
   PubMedGoogle Scholar
• Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. Am. J. Epidemiol. 177, 787–799 (2013).
   PubMedGoogle Scholar
• Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112, 4591–4597 (2008).
   PubMed Web of Science ®Google Scholar
• Miao CG, Yang YY, He X et al. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal. 25, 1828–1836 (2013).
   PubMedGoogle Scholar
• Di Leva G, Piovan C, Gasparini P et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 9, e1003311 (2013).
   PubMed Web of Science ®Google Scholar
• Duncan GS, Brenner D, Tusche MW, Brüstle A, Knobbe CB, Elia AJ et al. 2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation. Proc. Natl Acad. Sci. USA 109, 21034–21039 (2012).
   PubMed Web of Science ®Google Scholar
• Cutolo M. Hormone therapy in rheumatic diseases. Curr. Opin. Rheumatol. 22, 257–263 (2010).
   PubMedGoogle Scholar
• Cutolo M. Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res. Ther. 11(5), 126–131 (2009).
   PubMedGoogle Scholar
• Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34, 1–5 (1991).
   PubMed Web of Science ®Google Scholar
• Cutolo M. Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 26, 881–895 (2000).
   PubMedGoogle Scholar
• Ho SM, Lee MT, Lam HM, Leung YK. Estrogens and prostate cancer: etiology, mediators, prevention, and management. Endocrinol. Metab. Clin. North Am. 40, 591–614 (2011).
   PubMed Web of Science ®Google Scholar
• Lanzino M, Maris P, Sirianni R et al. DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation. Cell Death Dis. 4, e724–e730 (2013).
   Google Scholar
• Kawashima H, Nakatani T. Involvement of estrogen receptors in prostatic diseases. Int. J. Urol. 19, 512–522 (2012).
   PubMedGoogle Scholar
• Dayan M, Zinger H, Kalush F et al. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 90, 101–108 (1997).
   PubMed Web of Science ®Google Scholar
• Sthoeger ZM, Bentwich Z, Zinger H, Mozes E. The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus. J. Rheumatol. 21, 2231–2238 (1994).
   PubMedGoogle Scholar
• Chighizola C, Meroni PL. The role of environmental estrogens and autoimmunity. Autoimmun. Rev. 11, A493–A501 (2012).
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y. Environment and lupus-related diseases. Lupus 21, 241–250 (2012).
   PubMed Web of Science ®Google Scholar
• Sherlock JP, Filer AD, Isaacs JD, Buckley CD. What can rheumatologists learn from translational cancer therapy? Arthritis Res. Ther. 15, 114–118 (2013).
   PubMedGoogle Scholar
• Cutolo M. Chronobiology and the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol. 24, 312–318 (2012).
   PubMed Web of Science ®Google Scholar
• Cutolo M, Straub RH. Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun. Rev. 7, 223–228 (2008).
   PubMed Web of Science ®Google Scholar
• To H, Yoshimatsu H, Tomonari M et al. Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol. Int. 28, 267–274 (2011).
   PubMed Web of Science ®Google Scholar
• Cutolo M, Straub RH, Buttgereit F. Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann. Rheum. Dis. 67, 905–908 (2008).
   PubMed Web of Science ®Google Scholar
• Cutolo M. Rheumatoid. arthritis: circadian and circannual rhythms in RA. Nature Rev. Rheumatol. 7, 500–502 (2011).
   PubMedGoogle Scholar
• Mazzoccoli G, Sothern RB, Francavilla M et al. Hormone and cytokine circadian alteration in non-small cell lung cancer patients. Int. J. Immunopathol. Pharmacol. 25, 691–702 (2012).
   PubMedGoogle Scholar
• Rossetti S, Corlazzoli F, Gregorski A, Azmi NH, Sacchi N. Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis. Cell Cycle 11, 3691–3700 (2012).
   PubMed Web of Science ®Google Scholar
• Schmidt M, Weidler C, Naumann H, Anders S, Schölmerich J, Straub RHet al.. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res. Ther. 7, R938–R948 (2005).
   Google Scholar